Novartis India (NOVARTIND)
STALWARTFairStock Score: 9/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 1/1
Key Financials
| Current Price | ₹985.45 |
| Market Cap | ₹2,249.83 Cr |
| P/E Ratio | 23.14 |
| ROCE | 17% |
| ROE | 13.33% |
| Dividend Yield | 2.74% |
| Profit Growth | -36.78% |
| Debt/Equity | 0.01 |
| Sales Growth | -7.63% |
| Promoter Holding | 70.68% |
| 52-Week Range | ₹890 — ₹1,588.4 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹293.98 |
Novartis India trades with a P/E ratio of 23.14, ROCE of 17%, ROE of 13.33%, profit growth of -36.78%, debt-to-equity of 0.01. The FairStock Score of 9/100 flags concerns across multiple fundamental dimensions that investors should examine carefully.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer